National Bank of Canada’s ProMIS Neurosciences PMN Stock Holding History

National Bank of Canada’s Portfolio PMN Stock Details PMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4	Closed	-$37	–	3075
2025 Q3	$37	Hold	4	–	–	﹤0.01%	2797
2025 Q2	$42	Hold	4	–	–	﹤0.01%	2910
2025 Q1	$60	Hold	4	–	–	﹤0.01%	2742
2024 Q4	$83	Sell	4 -13	-76%	-$324	﹤0.01%	2808
2024 Q3	$526	Buy	17 +4	+31%	+$149	﹤0.01%	2479
2024 Q2	$501	Hold	13	–	–	﹤0.01%	2565
2024 Q1	$599	Hold	13	–	–	﹤0.01%	2585
2023 Q4	$452	Hold	13	–	–	﹤0.01%	2600
2023 Q3	$633	Hold	13	–	–	﹤0.01%	2633
2023 Q2	$1.26K	Hold	13	–	–	﹤0.01%	2528
2023 Q1	$1.56K	Hold	13	–	–	﹤0.01%	2479
2022 Q4	$1.5K	Hold	13	–	–	﹤0.01%	2534
2022 Q3	$2K	Buy	+13	New	+$1.92K	﹤0.01%	2526

Other funds holding PMN

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DEM

Disciplined Equity Management Neptune Beach, Florida $226M AUM 27.21% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

National Bank of Canada's PMN Position: Q4 2025 in Review

National Bank of Canada sold out of ProMIS Neurosciences (PMN) in Q4 2025, closing a stake of 4 shares — an estimated $37 sold.

National Bank of Canada first reported a position in PMN in Q3 2022 and held it in 13 quarters. The position peaked at $2K in Q3 2022. 9 funds tracked by Wall St. Rank hold PMN as of Q4 2025.

National Bank of Canada reported no remaining ProMIS Neurosciences position as of Q4 2025 after selling out during the quarter.
National Bank of Canada sold 4 ProMIS Neurosciences shares in Q4 2025, an estimated $37.
National Bank of Canada first reported a position in ProMIS Neurosciences in Q3 2022 and held it in 13 quarters.
National Bank of Canada's ProMIS Neurosciences position peaked at $2K in Q3 2022.
9 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q4 2025.

Based on National Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.